Please ensure Javascript is enabled for purposes of website accessibility
'People Are Losing Their Lives': California Sues Over Insulin Prices
gvw_ap_news
By Associated Press
Published 2 years ago on
January 14, 2023

Share

Getting your Trinity Audio player ready...

SACRAMENTO — California on Thursday announced it will sue the companies that make and promote most of the nation’s insulin, accusing them of scheming to illegally increase the price of the drug and demanding they return millions of dollars to some diabetics who state officials say were overcharged for the medicine they must have to survive.

The lawsuit, to be filed in Los Angeles County Superior Court by Attorney General Rob Bonta, is the latest in a parade of legal actions against these companies from states across the political spectrum — all who have accused the corporate giants of abusing their power to quash competition and boost their profits by keeping the price of insulin high.

A 2021 study by the RAND Corporation comparing the insulin prices of nearly three dozen countries found prices in the United States were about 10 times higher than everywhere else. The average price of a vial of insulin in the United States was $98, while in nearby Canada it was $12.

Attorneys general in Kansas, Arkansas, Mississippi, Minnesota, and Kentucky have all filed similar lawsuits in recent years.

“It is not a partisan issue,” said Bonta, a Democrat who was elected to his first full term in November. Bonta said state attorneys general from both major political parties “all say the same thing: That the status quo is unacceptable and problematic and awful.”

Bonta sued three companies that make insulin — Eli Lilly, Novo Nordisk, and Sanofi — and three companies that manage prescription drug programs that provide insulin — CVS Caremark, Express Scripts, and Optum Rx.

Bonta said the manufacturers raise the price of insulin “in lockstep with each other.” The prescription drug managers then negotiate with the manufacturers to get a percentage of that price in exchange for prominently promoting their high-price insulin over cheaper alternatives.

“People are losing their lives because they can’t afford the drug,” Bonta said.

Pharmaceutical Companies Deny Accusations

Daphne Dorsey, associate director for media relations for Eli Lilly, said the company is “disappointed by the California Attorney General’s false accusations.” She said the average monthly out-of-pocket cost for Lilly insulin is $21.80, a 44% decrease over the past five years. She urged anyone paying more than $35 a month for Lilly insulin to contact the company.

A representative for Novo Nordisk declined to comment on the lawsuit. But the company provided background information saying the net prices for its insulin products — the list price minus rebates and discounts — have fallen in each of the past five years “in large part to the significant rebates and discounts manufacturers pay to ensure access for patients.”

Mike DeAngelis, executive director of corporate communications for CVS Health, said the manufacturers alone set the list price for their products.

“Nothing in our agreements prevents drug manufacturers from lowering the prices of their insulin products and we would welcome such action,” he said. “Allegations that we play any role in determining the prices charged by manufacturers are false. We plan to vigorously defend against this complaint.”

A statement from Optum Rx said the company “welcomes the opportunity to show the California Office of the Attorney General, just as it has with other States Attorneys General, how we work every day to provide people with access to affordable drugs, including insulin.”

Canadian Scientists Discover Insulin a Century Ago, but Now Three Companies Dominate the Market

Insulin is made by the pancreas and is used by the human body to convert the food we eat into energy. People who have diabetes don’t produce enough insulin. People with Type 1 diabetes must take insulin every day to survive.

A team of Canadian scientists discovered insulin a century ago. They sold the patent to the University of Toronto for just $1, hoping to avoid a monopoly that could cause high prices. But eventually, the market came to be dominated by just three companies.

Kevin Wren, an activist associated with the California chapter of #Insulin4All, said he must take insulin every day to survive. Around 2009, Wren said he was working two jobs and did not have health insurance. He had to ration his insulin, taking less than the recommended dosage to make it last longer — a dangerous practice that he said ended up putting him in the hospital with ketoacidosis, a serious complication of diabetes.

Today, Wren says he has good health insurance and doesn’t have to ration his supply of insulin. He said he skirts the law each month by providing people insulin from someone else’s prescription “all so that they don’t have to ration.”

The big insulin manufacturing companies have assistance programs to help people purchase insulin. Novo Nordisk said in 2021 that more than a million people used some form of the company’s assistance when purchasing its insulin.

 

DON'T MISS

Wired Wednesday: CEMEX’s New Mining Plan for the San Joaquin River

DON'T MISS

Trump Fires NSC Officials a Day After Far-Right Activist Raises Concerns to Him

DON'T MISS

China Halts Approvals for New US Investment Projects

DON'T MISS

Measles Spreads to Central Texas; 5 States Have Active Outbreaks

DON'T MISS

Trump Tariff Fears Erase $2 Trillion From US Stocks

DON'T MISS

Startup Offers Controversial Microplastic Blood Cleansing Treatment

DON'T MISS

Senate Confirms Mehmet Oz to Take Lead of Medicare and Medicaid Agency

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Pence Will Receive the Profile in Courage Award From the JFK Library for His Actions on Jan. 6

DON'T MISS

Politics Turns Ugly for a Conservative Running for Fresno State Student Body President

UP NEXT

Startup Offers Controversial Microplastic Blood Cleansing Treatment

UP NEXT

Pence Will Receive the Profile in Courage Award From the JFK Library for His Actions on Jan. 6

UP NEXT

No More Calling ‘Shotgun?’ CA Could Ban Teens From Riding in Front Seat

UP NEXT

Diehard Baseball Fans in Sacramento Welcome Athletics and Hope They Stay Awhile

UP NEXT

Flores Homers, Matos and Wade Also Go Deep to Help Giants Cap Sweep of Astros

UP NEXT

Supreme Court Sides With the FDA in Its Dispute Over Sweet-Flavored Vaping Products

UP NEXT

California’s Schools Chief Has a $200,000 Salary and a Side Gig

UP NEXT

Trump Proposes Tax Deduction for Auto Loan Interest on US-Made Cars

UP NEXT

Western US Sees Sharp Increase in Extreme Weather Impact

UP NEXT

7-Year-Old Girl Was Killed by a Falling Boulder at a Lake Tahoe Ski Resort

Measles Spreads to Central Texas; 5 States Have Active Outbreaks

8 hours ago

Trump Tariff Fears Erase $2 Trillion From US Stocks

9 hours ago

Startup Offers Controversial Microplastic Blood Cleansing Treatment

9 hours ago

Senate Confirms Mehmet Oz to Take Lead of Medicare and Medicaid Agency

10 hours ago

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

12 hours ago

Pence Will Receive the Profile in Courage Award From the JFK Library for His Actions on Jan. 6

12 hours ago

Politics Turns Ugly for a Conservative Running for Fresno State Student Body President

12 hours ago

Pentagon’s Watchdog to Review Hegseth’s Use of Signal App to Convey Plans for Houthi Strike

12 hours ago

President Trump’s Tariffs Could Be the Political Tipping Point

13 hours ago

Order That Kept Water in the Kern River Reversed by 5th District Court of Appeal

13 hours ago

Wired Wednesday: CEMEX’s New Mining Plan for the San Joaquin River

GV Wire’s Edward Smith talks with KMPH Fox 26 “Great Day” anchor Christina Rodriguez about the possibility of CEMEX digging a 600-foot hole ...

7 hours ago

7 hours ago

Wired Wednesday: CEMEX’s New Mining Plan for the San Joaquin River

President Donald Trump speaks during an event to announce new tariffs in the Rose Garden at the White House, Wednesday, April 2, 2025, in Washington. (AP/Mark Schiefelbein)
7 hours ago

Trump Fires NSC Officials a Day After Far-Right Activist Raises Concerns to Him

8 hours ago

China Halts Approvals for New US Investment Projects

8 hours ago

Measles Spreads to Central Texas; 5 States Have Active Outbreaks

9 hours ago

Trump Tariff Fears Erase $2 Trillion From US Stocks

9 hours ago

Startup Offers Controversial Microplastic Blood Cleansing Treatment

Dr. Mehmet Oz, President Donald Trump's pick to lead the Centers for Medicare and Medicaid Services, seated right, gives a thumbs-up alongside his wife Lisa Oz, seated left, with friends and family after he testified at his confirmation hearing before the Senate Finance Committee, on Capitol Hill in Washington, Friday, March 14, 2025. (AP/Ben Curtis)
10 hours ago

Senate Confirms Mehmet Oz to Take Lead of Medicare and Medicaid Agency

12 hours ago

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

Help continue the work that gets you the news that matters most.

Search

Send this to a friend